-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to the latest report released by Bloomberg New Energy Finance, the global lithium hydroxide market may have a shortage by 2025, mainly because the market needs to plan for more lithium hydroxide for more high-performance electric vehicle batteries
.
In addition, as the demand for high-nickel chemicals surges, there may be a shortage
of this compound by 2027.
The market can now plan for new capacity, as it will take about 5 years for the plant to come online
.
By 2025, approximately 35% of the expected supply growth will come from spodumene to hydroxide conversion facilities
in Australia.
If these are delayed, the market could face shortages
by 2025.
Albemarle's Kemerton project will be the first conversion facility
to come on stream this year.
The ensemble model is not yet economically proven and may face potential delays and concurrency effects
during acceleration.
In addition to the Albemarle plant, seven new hydroxide plants
will be built in China this year.
Orocobre/Galaxy's new Nara plant in Japan will test a new supply chain structure as the company seeks to diversify, capture more value and reduce its dependence on
the Chinese market.
According to the latest report released by Bloomberg New Energy Finance, the global lithium hydroxide market may have a shortage by 2025, mainly because the market needs to plan for more lithium hydroxide for more high-performance electric vehicle batteries
.
In addition, as the demand for high-nickel chemicals surges, there may be a shortage
of this compound by 2027.
The market can now plan for new capacity, as it will take about 5 years for the plant to come online
.
By 2025, approximately 35% of the expected supply growth will come from spodumene to hydroxide conversion facilities
in Australia.
If these are delayed, the market could face shortages
by 2025.
Albemarle's Kemerton project will be the first conversion facility
to come on stream this year.
The ensemble model is not yet economically proven and may face potential delays and concurrency effects
during acceleration.
In addition to the Albemarle plant, seven new hydroxide plants
will be built in China this year.
Orocobre/Galaxy's new Nara plant in Japan will test a new supply chain structure as the company seeks to diversify, capture more value and reduce its dependence on
the Chinese market.
